AZTR
Azitra Inc
NYSE MKT: AZTR · HEALTHCARE · BIOTECHNOLOGY
$0.25
+0.52% today
Updated 2026-04-29
Market cap
$3.56M
P/E ratio
—
P/S ratio
239.97x
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$0 – $2
Volume
14.7M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$1.35
+440.00%
12-Month target
$0.27
+8.00%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.21M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $284000.00 | $686000.00 | $7.50M | $0.00 | $0.00 |
| Net income | $-10.68M | $-11.28M | $-8.97M | $-10.96M | $-2.23M |
| EPS | — | — | — | — | $-2.25 |
| Free cash flow | $-8.69M | $-7.68M | $-10.56M | $-35.44M | $-5.21M |
| Profit margin | -3,760.69% | -1,644.87% | -119.57% | — | — |
Peer comparison
Smart narrative
Azitra Inc trades at $0.25. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is Azitra Inc's stock price?
Azitra Inc (AZTR) trades at $0.25.
Is Azitra Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Azitra Inc (AZTR)?
The analyst target price is $1.35, representing +440.0% upside from the current price of $0.25.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio239.97x
ROE-230.70%
Beta-2.18
50D MA$0.21
200D MA$0.54
Shares out0.02B
Float0.02B
Short ratio—
Avg volume14.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—